CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade AstraZeneca PLC - GBP - AZNl CFD

122.41
1.91%
Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 11:00 11:03 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.32
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.025295 %
Charges from full value of position ($-4.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.025295%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003377 %
Charges from full value of position ($0.64)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003377%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.65
Currency GBP
Margin 5%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 120.11
Open 122.21
1-Year Change 21.32%
Day's Range 121.61 - 122.81
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 12, 2024 122.41 1.00 0.82% 121.41 122.89 121.41
Jul 11, 2024 120.11 -0.94 -0.78% 121.05 121.47 120.11
Jul 10, 2024 120.43 0.83 0.69% 119.60 120.53 119.42
Jul 9, 2024 118.88 -1.19 -0.99% 120.07 121.05 118.88
Jul 8, 2024 120.09 0.22 0.18% 119.87 121.05 119.87
Jul 5, 2024 119.36 -1.47 -1.22% 120.83 121.71 119.36
Jul 4, 2024 121.01 0.74 0.62% 120.27 121.65 120.17
Jul 3, 2024 119.79 -1.26 -1.04% 121.05 121.15 119.58
Jul 2, 2024 120.69 -1.30 -1.07% 121.99 122.75 120.27
Jul 1, 2024 122.87 -0.62 -0.50% 123.49 123.73 122.15
Jun 28, 2024 123.77 2.60 2.15% 121.17 124.39 121.17
Jun 27, 2024 122.71 -1.98 -1.59% 124.69 125.37 122.71
Jun 26, 2024 124.15 -0.80 -0.64% 124.95 126.87 124.15
Jun 25, 2024 125.45 1.64 1.32% 123.81 125.57 122.61
Jun 24, 2024 124.85 1.20 0.97% 123.65 124.93 123.07
Jun 21, 2024 123.61 -0.48 -0.39% 124.09 125.11 122.75
Jun 20, 2024 123.81 1.68 1.38% 122.13 123.93 122.13
Jun 19, 2024 122.21 0.08 0.07% 122.13 123.57 121.43
Jun 18, 2024 123.93 0.58 0.47% 123.35 124.57 123.31
Jun 17, 2024 123.63 0.02 0.02% 123.61 125.35 123.61

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

AstraZeneca - GBP Company profile

About AstraZeneca plc

AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.

Industry: Pharmaceuticals (NEC)

1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB

People also watch

XRP/USD

0.53 Price
+11.170% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,411.42 Price
-0.180% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.60

US100

20,336.40 Price
+0.570% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

59,584.10 Price
+3.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading